Cargando…
Epidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung
INTRODUCTION: Approximately 70% of lung adenocarcinomas express TTF-1. EGFR mutations are present in 13-15% of Western adenocarcinoma patients. This paper investigates TTF1 as a negative predictor of mutant EGFR in lung adenocarcinomas. RESULTS: In the pilot cohort (N = 301) two of 224 specimens pos...
Autores principales: | Somaiah, Neeta, Fidler, Mary Jo, Garrett-Mayer, Elizabeth, Wahlquist, Amy, Shirai, Keisuke, Buckingham, Lela, Hensing, Thomas, Bonomi, Philip, Simon, George R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278331/ https://www.ncbi.nlm.nih.gov/pubmed/25594059 |
Ejemplares similares
-
The Relationship between TTF-1 Expression and EGFR Mutations in Lung Adenocarcinomas
por: Shanzhi, Wan, et al.
Publicado: (2014) -
Thyroid transcription factor 1 (TTF‐1) negativity as a predictor of unfavorable response to EGFR‐TKI therapy in advanced lung adenocarcinoma patients with
EGFR
mutations
por: Ding, Xiaosheng, et al.
Publicado: (2023) -
TTF1 Expression in Pulmonary Metastatic Rectal Adenocarcinoma
por: Aversa, Sara, et al.
Publicado: (2018) -
Epidermal Growth Factor Receptor (EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma
por: Makinoshima, Hideki, et al.
Publicado: (2014) -
Prognostic relevance of TTF-1 expression in stage I adenocarcinoma
por: Zhou, Chao, et al.
Publicado: (2017)